Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage

References

• Aksenov MY, Aksenova MV, Nath A, Ray PD, Mactutus CF, Booze RM (2006). Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27: 217–228.
   PubMed Web of Science ®Google Scholar
• Aksenov MY, Hasselrot U, Wu G, Nath A, Anderson C, Mactutus CF, Booze RM (2003). Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res 987: 1–9.
   PubMedGoogle Scholar
• Aylward EH, Henderer JD, McArthur JC, Brettschneider PD, Harris GJ, Barta PE, Pearlson GD (1993). Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43: 2099–2104.
   PubMed Web of Science ®Google Scholar
• Bachis A, Aden SA, Nosheny RL, Andrews PM, Mocchetti I (2006). Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis. J Neurosci 26: 6771–6780.
   PubMedGoogle Scholar
• Banisadr G, Fontanges P, Haour F, Kitabgi P, Rostene W, Melik Parsadaniantz S (2002). Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci 16: 1661–1671.
   Google Scholar
• Bennett BA, Rusyniak DE, Hollingsworth CK (1995). HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. Brain Res 705: 168–176.
   Google Scholar
• Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A (2001). CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4: 702–710.
   PubMed Web of Science ®Google Scholar
• Block ML, Wu X, Pei Z, Li G, Wang T, Qin L, Wilson B, Yang J, Hong JS, Veronesi B (2004). Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J 18: 1618–1620.
   PubMed Web of Science ®Google Scholar
• Boisse L, Gill MJ, Power C (2008). HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin 26: 799–819, x.
   PubMed Web of Science ®Google Scholar
• Boven LA, Gomes L, Hery C, Gray F, Verhoef J, Portegies P, Tardieu M, Nottet HS (1999). Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol 162: 4319–4327.
   PubMedGoogle Scholar
• Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB (1988). Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639–642.
   PubMed Web of Science ®Google Scholar
• Chao CC, Gekker G, Sheng WS, Hu S, Tsang M, Peterson PK (1994). Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression. J Pharmacol Exp Ther 269: 198–203.
   Web of Science ®Google Scholar
• Chao CC, Hu S, Peterson PK (1995). Modulation of human microglial cell superoxide production by cytokines. J Leukoc Biol 58: 65–70.
   PubMed Web of Science ®Google Scholar
• Chao CC, Hu S, Tsang M, Weatherbee J, Molitor TW, Anderson WR, Peterson PK (1992). Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury. J Clin Invest 90: 1786–1793.
   Google Scholar
• Corasaniti MT, Strongoli MC, Piccirilli S, Nistico R, Costa A, Bilotta A, Turano P, Finazzi-Agro A, Bagetta G (2000). Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-74389G. Biochem Biophys Res Commun 274: 664–669.
   PubMed Web of Science ®Google Scholar
• Cosenza MA, Zhao ML, Si Q, Lee SC (2002). Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 12: 442–455.
   PubMed Web of Science ®Google Scholar
• Czub S, Czub M, Koutsilieri E, Sopper S, Villinger F, Muller JG, Stahl-Hennig C, Riederer P, Ter Meulen V, Gosztonyi G (2004). Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs. Acta Neuropathol (Berl) 107: 216–226.
   Google Scholar
• D'Aversa TG, Eugenin EA, Berman JW (2005). NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. J Neurosci Res 81: 436–446.
   PubMed Web of Science ®Google Scholar
• Dong JF, Detta A, Bakker MH, Hitchcock ER (1993). Direct interaction with target-derived glia enhances survival but not differentiation of human fetal mesencephalic dopaminergic neurons. Neuroscience 56: 53–60.
   Google Scholar
• Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM (2009). In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 Tat-induced alterations in dopamine transmission. Synapse 63: 181–185.
   Google Scholar
• Gao HM, Liu B, Zhang W, Hong JS (2003). Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J 17: 1954–1956.
   PubMedGoogle Scholar
• Garden GA, Budd SL, Tsai E, Hanson L, Kaul M, D'Emilia DM, Friedlander RM, Yuan J, Masliah E, Lipton SA (2002). Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J Neurosci 22: 4015–4024.
   PubMedGoogle Scholar
• Gelman BB, Spencer JA, Holzer CE, Soukup VM (2006). Abnormal striatal dopaminergic synapses in national neuroAIDS tissue consortium subjects with HIV encephalitis. J NeuroImmune Pharmacol 2: 410–420.
   Google Scholar
• Gendelman HE (ed) (2005). The neurology of AIDS 2nd ed. Oxford, New York: Oxford University Press.
   Google Scholar
• Ghorpade A, Persidsky Y, Swindells S, Borgmann K, Persidsky R, Holter S, Cotter R, Gendelman HE (2005). Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjects. J Neuroimmunol 163: 145–156.
   PubMedGoogle Scholar
• Gonzalez-Scarano F, Martin-Garcia J (2005). The neuropathogenesis of AIDS. Nat Rev Immunol 5: 69–81.
   PubMed Web of Science ®Google Scholar
• Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, Turchan J, Nath A, Mattson MP (2004). Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol 55: 257–267.
   PubMed Web of Science ®Google Scholar
• Hu S, Ali H, Sheng WS, Ehrlich LC, Peterson PK, Chao CC (1999). Gp-41-mediated astrocyte inducible nitric oxide synthase mRNA expression: involvement of interleukin-1beta production by microglia. J Neurosci 19: 6468–6474.
   Google Scholar
• Hu S, Cheeran MC, Sheng WS, Ni HT, Lokensgard JR, Peterson PK (2006). Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells. J Pharmacol Exp Ther 318: 1280–1286.
   Google Scholar
• Hu S, Sheng WS, Lokensgard JR, Peterson PK (2002). Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 42: 829–836.
   PubMed Web of Science ®Google Scholar
• Hu S, Sheng WS, Lokensgard JR, Peterson PK (2005). Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis 191: 886–889.
   PubMed Web of Science ®Google Scholar
• Itoh K, Mehraein P, Weis S (2000). Neuronal damage of the substantia nigra in HIV-1 infected brains. Acta Neuropathol (Berl) 99: 376–384.
   PubMed Web of Science ®Google Scholar
• Jones MV, Bell JE, Nath A (2000). Immunolocalization of HIV envelope gp120 in HIVencephalitis with dementia. AIDS 14: 2709–2713.
   PubMed Web of Science ®Google Scholar
• Kaul M, Lipton SA (1999). Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 96: 8212–8216.
   PubMed Web of Science ®Google Scholar
• Kaul M, Lipton SA (2006). Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 1: 138–151.
   PubMed Web of Science ®Google Scholar
• Kaul M, Zheng J, Okamato S, Gendelman HE, Lipton SA (2005). HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 12: 893–904.
   Google Scholar
• Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089–1093.
   PubMed Web of Science ®Google Scholar
• Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P (2002a). Involvement of dopamine in the progression of AIDS dementia complex. J Neural Transm 109: 399–410.
   Google Scholar
• Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P (2002b). Parkinsonism in HIV dementia. J Neural Transm 109: 767–775.
   PubMed Web of Science ®Google Scholar
• Lawson LJ, Perry VH, Dri P, Gordon S (1990). Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39: 151–170.
   PubMed Web of Science ®Google Scholar
• Lee SC, Dickson DW, Liu W, Brosnan CF (1993). Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol 46: 19–24.
   PubMed Web of Science ®Google Scholar
• Liu B, Du L, Hong JS (2000). Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 293: 607–17.
   PubMed Web of Science ®Google Scholar
• Mattson MP, Haughey NJ, Nath A (2005). Cell death in HIV dementia. Cell Death Differ 12 (Suppl 1): 893–904.
   PubMedGoogle Scholar
• Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ (1998). Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A 95: 14500–14505.
   PubMed Web of Science ®Google Scholar
• Minghetti L, Visentin S, Patrizio M, Franchini L, Ajmone-Cat MA, Levi G (2004). Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions. Neurochem Res 29: 965–978.
   PubMed Web of Science ®Google Scholar
• Mocchetti I, Nosheny RL, Tanda G, Ren K, Meyer EM (2007). Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system. Ann N Y Acad Sci 1122: 144–154.
   PubMed Web of Science ®Google Scholar
• Mollace V, Nottet HS, Clayette P, Turco MC, Muscoli C, Salvemini D, Perno CF (2001). Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci 24: 411–416.
   PubMed Web of Science ®Google Scholar
• Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser KF, Mattson M (2000). Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 14: 222–227.
   PubMed Web of Science ®Google Scholar
• Nosheny RL, Ahmed F, Yakovlev A, Meyer EM, Ren K, Tessarollo L, Mocchetti I (2007). Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo. Eur J Neurosci 25: 2275–2284.
   PubMedGoogle Scholar
• Nosheny RL, Bachis A, Aden SA, De Bernardi MA, Mocchetti I (2006). Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. J Neurobiol 66: 1311–1321.
   PubMedGoogle Scholar
• Paul RH, Brickman AM, Navia B, Hinkin C, Malloy PF, Jefferson AL, Cohen RA, Tate DF, Flanigan TP (2005). Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. J Neuropsychiatry Clin Neurosci 17: 167–171.
   PubMed Web of Science ®Google Scholar
• Peterson PK, Hu S, Anderson WR, Chao CC (1994). Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J Infect Dis 170: 457–460.
   Google Scholar
• Pocernich CB, Sultana R, Mohmmad-Abdul H, Nath A, Butterfield DA (2005). HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations. Brain Res Brain Res Rev 50: 14–26.
   Google Scholar
• Rock RB, Hu S, Deshpande A, Munir S, May BJ, Baker CA, Peterson PK, Kapur V (2005). Transcriptional response of human microglial cells to interferon-gamma. Genes Immun 6: 712–719.
   PubMed Web of Science ®Google Scholar
• Sardar AM, Czudek C, Reynolds GP (1996). Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 7: 910–912.
   Google Scholar
• Scheller C, Sopper S, Jenuwein M, Neuen-Jacob E, Tatschner T, Grunblatt E, ter Meulen V, Riederer P, Koutsilieri E (2005). Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation. J Neurochem 95: 377–387.
   Google Scholar
• Sheng WS, Hu S, Hegg CC, Thayer SA, Peterson PK (2000). Activation of human microglial cells by HIV-1 gp41 and Tat proteins. Clin Immunol 96: 243–251.
   Google Scholar
• Silani V, Mariani D, Donato FM, Ghezzi C, Mazzucchelli F, Buscaglia M, Pardi G, Scarlato G (1994). Development of dopaminergic neurons in the human mesencephalon and in vitro effects of basic fibroblast growth factor treatment. Exp Neurol 128: 59–76.
   Google Scholar
• Silvers JM, Aksenov MY, Aksenova MV, Beckley J, Olton P, Mactutus CF, Booze RM (2006). Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains. J NeuroVirol 12: 140–145.
   PubMed Web of Science ®Google Scholar
• Stefano GB, Sawada M, Smith EM, Hughes TK (1993). Selective effects of human immunodeficiency virus (HIV) gp120 on invertebrate neurons. Cell Mol Neurobiol 13: 569–577.
   Google Scholar
• Turchan-Cholewo J, Liu Y, Gartner S, Reid R, Jie C, Peng X, Chen KC, Chauhan A, Haughey N, Cutler R, Mattson MP, Pardo C, Conant K, Sacktor N, McArthur JC, Hauser KF, Gairola C, Nath A (2006). Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and l-deprenyl. Neurobiol Dis 23: 109–119.
   PubMed Web of Science ®Google Scholar
• Wallace DR, Dodson S, Nath A, Booze RM (2006). Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function. Synapse 59: 51–60.
   Google Scholar
• Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS (2004). Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127: 2452–2458.
   PubMed Web of Science ®Google Scholar
• Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986). Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 83: 7089–7093.
   PubMed Web of Science ®Google Scholar
• Yang Z, Yang S, Qian SY, Hong JS, Kadiiska MB, Tennant RW, Waalkes MP, Liu J (2007). Cadmium-induced toxicity in rat primary mid-brain neuroglia cultures: role of oxidative stress from microglia. Toxicol Sci 98: 488–494.
   PubMedGoogle Scholar
• Yao H, Allen JE, Zhu X, Callen S, Buch S (2009). Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways. J NeuroVirol 15: 164–175.
   Web of Science ®Google Scholar
• Yi Y, Lee C, Liu QH, Freedman BD, Collman RG (2004). Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis. J NeuroVirol 10 (Suppl 1): 91–96.
   Google Scholar